Digital Pathology Podcast

• 142. First All-in-One Digital Pathology Tool: Techcyte's Fusion Platform to Improve Pathologists' Workflow and Integrate AI.

  Send us a textIn this episode, I talk with Tiffany Chen, MD, and Ben Cahoon from Techcyte about Fusion, their new digital pathology platform. Fusion integrates clinical and anatomic pathology workflows, AI algorithms, and electronic health records—all into one streamlined experience.We explore how Fusion simplifies case management, improves diagnostic accuracy, and brings AI-powered pathology into routine practice. Plus, we discuss the importance of open standards, partnerships with Mayo Clinic, and why flexible integration is key for healthcare innovation.If you’re passionate about digital pathology, AI, and advancing patient care, this is a conversation you don’t want to miss!✨ Key Highlights- Introduction of Techcyte’s Fusion platform: bridging clinical and anatomic pathology workflows- How Fusion integrates AI, EHRs, and LIS systems using open standards (FHIR, DICOM, HL7)- Collaborations with Mayo Clinic and BD for scalable global deployment- AI marketplace support: Fusion enables the integration of internal, partner, and institutional AI models- Impact of AI on cytology workflows and pathology screening- Flexibility for lab-driven or PACS-driven workflows- Future plans: Subspecialty-focused AI enhancements and smart synoptic reporting integration- The importance of interoperability and data standardization for healthcare AIThis Episode's Resources:Techcyte Fusion Platform: https://techcyte.com/fusion/ Support the showBecome a Digital Pathology Trailblazer get the "Digital Pathology 101" FREE E-book and join us!

  --------  

  35:14

  --------

  35:14
• 141: Digital Pathology Tools: How To Get Them FDA Approved?

  Send us a textWhy do so many digital pathology tools stall before they ever reach patients? In this USCAP 2025 special sponsored by Muse Microscopy, I talk with Esther Abels, founder of SolarisRTC, regulatory strategist, and the force behind the first FDA-cleared whole slide imaging system.We break down what startups and established companies must do from day one to succeedbin getting their devices through the FDA. Hint: regulatory strategy isn’t a final step—it’s your starting line.🧠 What You’ll Learn:[00:01:00] Why regulatory planning must start at inception[00:03:00] How Esther helped Philips get the first scanner FDA cleared[00:05:00] Clinical study design, documentation, and risk strategy[00:08:00] Timeline expectations for clearance and review[00:10:00] The role of consultants vs. internal regulatory teams[00:13:00] Using meta-analysis, synthetic data, and publications[00:15:00] How the DPA is driving system decoupling & AI regulatory clarity🎧 Tune in to learn how to build compliance into innovation—from tissue imaging to AI-powered diagnostics. #DigitalPathology #RegulatoryStrategy #FDAApproval #ClinicalInnovation #PathologyTools #MUSEmiscroscopy #sponsored #USCAP2025Support the showBecome a Digital Pathology Trailblazer get the "Digital Pathology 101" FREE E-book and join us!

  --------  

  18:55

  --------

  18:55
• 140: How Are Pathologists in Japan Using AI and Digital Tools? Podcast with Dr. Robert Osamura

  Send us a textCan you still call it “digital transformation” if you’re scanning slides and still tethered to glass?This special episode, recorded at USCAP and sponsored by MUSE Microscopy, features Dr. Robert Osamura from Japan. We explore how digital pathology is being implemented across Japanese hospitals, how regulations shape adoption, and where AI and tools like MUSE could fit in a geographically complex healthcare system. We also discuss the real-world utility of direct-to-digital tools for intraoperative diagnostics and how AI is changing confidence, not replacing pathologists.👉 Tune in for an insightful conversation bridging tradition and innovation in digital pathology.⏱ Highlights with Timestamps[00:00] Starting digital pathology with glass is still required[02:00] Dr. Osamura’s current practice in a community hospital near Tokyo[03:30] Everyday use of digital pathology for biopsy cases[04:30] Technical and logistical advantages of digital images[05:45] How Japan’s island geography benefits from digital workflows[07:15] Government regulations: dual review (glass + digital)[08:40] Adoption challenges and culture around microscopes[10:00] The psychological shift away from glass reliance[11:30] Potential use cases for MUSE technology in Japan[13:20] Direct-to-digital for frozen sections and rapid diagnosis[15:00] Hospital-to-hospital collaborations in Japan[16:30] Reimbursement and scanner costs as limiting factors[17:45] AI as a confidence enhancer, not a replacement[18:45] Future of pathology as more patient-centeredEpisode Resources:https://musemicroscopy.com/#sponsored #musemicroscopy #USCAPSupport the showBecome a Digital Pathology Trailblazer get the "Digital Pathology 101" FREE E-book and join us!

  --------  

  24:18

  --------

  24:18
• 139: Why AI Won't Replace Pathologists and How It Can Help Them Thrive

  Send us a textWhy are so many pathologists still afraid of going digital? In this USCAP special episode sponsored by Muse Microscopy, I talk with Dr. Sarah Dry, Chair of Pathology and Laboratory Medicine at UCLA, about real-world adoption, AI fear, and how change is best managed when it's people-led.From her early digital research lab in 2007 to pioneering innovative workflows at UCLA today, Dr. Dry knows how direct-to-digital imaging and AI can enhance, not replace, our work.🧠 Key Takeaways:[00:01:00] Fear of change and pathologist pushback[00:03:00] Direct-to-digital imaging & frozen sectios[00:05:00] Redefining histotech roles amid tech shortages[00:08:00] CAP standards, tissue storage & digital-first futures[00:12:00] Specialty-specific barriers to adoption[00:15:00] Why AI is a pathologist extender, not a threat[00:18:00] What AI can automate—cell counts, GI screenings & reports[00:20:00] Managing change and getting early adopters onboard🎧 Tune in to hear how digital pathology becomes scalable, without losing the people at its core.#DigitalPathology #AIinPathology #ChangeManagement #PathologistLeadership #WomenInSTEMSupport the showBecome a Digital Pathology Trailblazer get the "Digital Pathology 101" FREE E-book and join us!

  --------  

  20:24

  --------

  20:24
• 138: Future of Pathology Across Continents Podcast with Dr. Junya Fukuoka and Dr. Norman Zerbe

  Send us a textWhy is digital pathology progressing faster in some parts of the world than others? In this international episode sponsored by Muse Microscopy, I sit down with Junya Fukuoka and Norman Zerbe—presidents of the Asian and European Societies of Digital Pathology—to unpack how cultural, regulatory, and infrastructural forces are shaping progress differently across continents.From direct-to-digital tissue imaging considered an alternative to frozen sections in Asia, to legal hurdles in Europe, we discuss what’s advancing adoption—and what’s still holding it back.🧠 Key Takeaways:[00:01:00] Direct-to-digital tissue imaging and frozen sections[00:03:00] Glass-free pathology and multimodal imaging potential[00:04:00] Legal and regulatory challenges in Europe[00:05:00] Innovation through low-resource workarounds in Asia[00:07:00] Building cross-continental collaboration between societies[00:08:00] The rise of digital pathology superstars across Asia[00:09:00] Upcoming European and Asian conferences and initiatives🎧 Tune in to hear how Asia and Europe are reimagining pathology—one regulation, one society, and one scanner at a time.Event Details: 21st European Congress on Digital Pathology2nd Annual Congress of the Asian Society of Digital Pathology 2025 #DigitalPathology #GlobalDiagnostics #AsianSocietyPathology #EuropeanPathology #DirectToDigitalSupport the showBecome a Digital Pathology Trailblazer get the "Digital Pathology 101" FREE E-book and join us!

  --------  

  8:57

  --------

  8:57

Más podcasts de Salud y forma física

Podcasts a la moda de Salud y forma física

Acerca de Digital Pathology Podcast